TNFSF10 and hepatocellular carcinoma: Notably, it has been reported that HCC cells acquired a resistant phenotype to TRAIL through the compensatory activation of NF-κB by facilitating the IKK-mediated IκB degradation and subsequent nuclear translocation of p65, leading to the up-regulation of many anti-apoptotic proteins 56,57.